A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)

Haukeland Universitetssjukehus ( Site 1601), Bergen

New York Medical College ( Site 0215), Valhalla

Faculty of Medicine Siriraj Hospital ( Site 0701), Bangkok

Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0801), Prague

North Estonia Medical Centre Foundation ( Site 0900), Tallinn

AHN West Penn Hospital ( Site 0212), Pittsburgh

Georgetown University Medical Center ( Site 0204), Washington D.C.

Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1503), Rozzano

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa di Ematologia ( Site 1501), Milan

University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0211), Baltimore

Skånes Universitetssjukhus Lund ( Site 2100), Lund

Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2000), Madrid

Northside Hospital ( Site 0206), Atlanta

Mega Medipol-Hematology ( Site 2308), Istanbul

Dokuz Eylül Üniversitesi-Hematology ( Site 2304), Izmir

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca ( Site 2003), Salamanca

"IRCCS - AOU di Bologna-Istituto di Ematologia L. e A. Seragnoli ( Site 1500)", Bologna

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus

University Hospitals Cleveland Medical Center ( Site 0222), Cleveland

University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0217), Cincinnati

Franciscan St. Francis Health ( Site 0225), Indianapolis

University of Michigan ( Site 0200), Ann Arbor

Karmanos Cancer Institute ( Site 0216), Detroit

Maharaj Nakorn Chiang Mai Hospital ( Site 0702), Muang

MEDICAL COLLEGE OF WISCONSIN ( Site 0234), Milwaukee

Ondokuz Mayıs Universitesi ( Site 2306), Samsun

Avera Cancer Institute- Research ( Site 0233), Sioux Falls

University of Chicago Medical Center ( Site 0207), Chicago

Karadeniz Teknik Universitesi Tip Fakultesi-Hematology ( Site 2307), Trabzon

Saint Louis University Cancer Center ( Site 0209), St Louis

Centre Hospitalier de la Côte Basque ( Site 1002), Bayonne

Sourasky Medical Center ( Site 1400), Tel Aviv

Pitie Salpetriere University Hospital-Clinical haematology ( Site 1000), Paris

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1502), Napoli

Innovative Clinical Research Institute ( Site 0202), Whittier

St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0229), Orange

Beijing Cancer hospital ( Site 2900), Beijing

The First Hospital of Jilin University-Hematology ( Site 2910), Changchun

Fudan University Shanghai Cancer Center ( Site 2908), Shanghai

Shanghai East Hospital ( Site 2902), Shanghai

Tianjin Medical University Cancer Institute and Hospital-lymphoma ( Site 2901), Tianjin

The First Affiliated Hospital, Zhejiang University-Bone marrow transplant centre ( Site 2912), Hangzhou

Hunan Cancer Hospital ( Site 2905), Changsha

Wuhan Union Hospital ( Site 2906), Wuhan

Henan Cancer Hospital-hematology department ( Site 2903), Zhengzhou

SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal Medicine ( Site 2907), Guangzhou

West China Hospital of Sichuan University-Head and Neck Oncology ( Site 2911), Chengdu

James Lind Centro de Investigación del Cáncer ( Site 2705), Temuco

Clínica Alemana de Santiago ( Site 2704), Santiago

Soroka Medical Center-Hematology Department ( Site 1403), Beersheba

Shaare Zedek Medical Center ( Site 1404), Jerusalem

Hadassah Medical Center ( Site 1402), Jerusalem

Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203), Boston

Atlantic Health System Morristown Medical Center ( Site 0213), Morristown

Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0100), Toronto

Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0800), Brno

Evangelismos General Hospital of Athens ( Site 1214), Athens

"General Hospital of Athens Laiko-Hematology Department ( Site 1213)", Athens

Oslo universitetssykehus, Radiumhospitalet ( Site 1600), Oslo

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1707), Krakow

Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site, Wroclaw

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( S, Warsaw

Szpitale Pomorskie Sp. z o. o.-Hematology and Bone Marrow Transplantation Department ( Site 1702), Gdynia

Pratia Onkologia ( Site 1701), Katowice

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 0601), Seoul

Samsung Medical Center ( Site 0600), Seoul

Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 2002), L'Hospitalet Del Llobregat

Hospital Universitari Vall d'Hebron ( Site 2005), Barcelona

Karolinska Universitetssjukhuset Solna ( Site 2102), Solna

Ankara University Hospital Cebeci-hematology ( Site 2300), Ankara

Hacettepe Universitesi-Department of Hematology ( Site 2302), Ankara